한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology)

  • 제27권3호
  • /
  • Pages.84-95
  • /
  • 2014
  • /
  • 1738-6640(pISSN)
  • /
  • 2234-4020(eISSN)
대한한방안이비인후피부과학회 (The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology)
권호 표지
DOI QR코드

DOI QR Code

마황 추출물 투여가 Ovalbumin으로 유발된 마우스 알레르기성 천식에 미치는 영향

Effects of Ephedra sinica (ES) Extract on the Ovalbumin-Induced Allergid Asthma in Mice

  • 조은희 (원광대학교 한의과대학 침구과) ;
  • 조일주 (원광대학교 한의과대학 본초학교실) ;
  • 박성주 (원광대학교 한의과대학 본초학교실) ;
  • 조소현 (원광대학교 한의과대학 안이비인후피부과) ;
  • 박민철 (원광대학교 한의과대학 안이비인후피부과)
  • Jo, Eun-Hee (Dep. of Acupuncture and Moxibustion, Wonkwang University) ;
  • Jo, Il-Joo (Dep. of Herbology, Wonkwang University) ;
  • Park, Seong-Ju (Dep. of Herbology, Wonkwang University) ;
  • Jo, So-Hyun (Dep. of Oriental Ophthalmology and Otolaryngology and Dermatology, Wonkwang University) ;
  • Park, Min-Cheol (Dep. of Oriental Ophthalmology and Otolaryngology and Dermatology, Wonkwang University)
  • 투고 : 2014.07.02
  • 심사 : 2014.08.14
  • 발행 : 2014.08.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : Ephedra sinica (ES) has has been used as remedy of allergic diseases for a long time in Korea. In the present study, we investigated the anti-allergic effects of ES on experimental allergic asthma mouse model using ovalbumin (OVA). Methods : BALB/c mice were sensitized and challenged with 100 ug of OVA and 1 mg of aluminum potassium sulfate of 0.2 ml phosphate-buffered saline(PBS) intraperitoneally on day 1 and 15. mice were challenged on 3 consecutive days with 5% OVA and AHR was assessed 24 h after the last challenge. we examined the lung histology, airway hyper sensitivity, total inflammatory cell count in bronchoaveloar lavage fluid(BALF), Th2-associated cytokines production and IgE production. Results : ES potently inhibited the lung damage and the development of Penh. ES also reduced the number of BAL cells during OVA-induced allergic asthma. Furthermore, ES inhibited cytokines production such as IL-4, IL-13 productions, and IgE level of serum. Conclusion : These results suggest that ES may inhibit the production of IL-4, IL-13, IgE and infiltration of inflammatory cell and be beneficial oriental medicine for allergic asthma.

키워드

참고문헌

  1. Lee HG, Jeong HG. Donguiipyeogyeonaegwahak. Seoul:Art Dongbang. 1999;187-202.
  2. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143-78. https://doi.org/10.1183/09031936.00138707
  3. Busse WW, Lemanske RF Jr. Asthma. N. Engl. J. Med. 2001;344(5):350-62. https://doi.org/10.1056/NEJM200102013440507
  4. Okayama Y, Hagaman DD, Metcalfe DD. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. J Immunol. 2001;166(7):4705-12. https://doi.org/10.4049/jimmunol.166.7.4705
  5. Asthma and Allergic Disease. Seoul: Koonja publishment co. 2002:13-33, 244-50.
  6. Shin MG. Clinical Traditional Herbology. Seoul: Younglimsa. 2002:322-4.
  7. Association of studying herbs. Pharmacognosy. Korea Teaching and books co. 1985:292-94.
  8. Lee SI, Ahn DK, Shin MG. Clinical application of herbal medicine. Seoul:Seoungbosa. 1982:44-52.
  9. Chae IS. Shanghanlunyeokgeon. Seoul: Komunsa. 1987:298-9.
  10. Wang BM, Wang l. Shinnongbonchogyeonggojeung. Gillim: Gillimgwahakgisul Pub. 1988:316-7.
  11. Yong JC. Clinical Chinese pharmacy. Beijing:Inminwisang Pub. 1989:109-10.
  12. Jo GJ. Treatment of Poisoning of Chinese medicine. Sichuan:Seongdojeonpagongjeonghakwon Pub. 1989:274-5.
  13. Yeo MC, Yu MB. Poising and treatment of Chinese medicine. Junggwang Uni. Pub. 1993:27-9.
  14. Mun GS. Component and Utilization of medicinal herb. Seoul:Ilwolseogak. 1994.:124-5.
  15. Peebles RS Jr, Sheller JR, Johnson JE, Mitchell DB, Graham BS. Respiratory Syncytial Virus Infection Prolonges Methacholine-Induced Airway Hyperresponsiveness in Ovalbumin-Sensitized Mice. J Med Viro. 1999;57(2):186-92. https://doi.org/10.1002/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q
  16. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-9. https://doi.org/10.1056/NEJM199010113231505
  17. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989;139(3):806-17. https://doi.org/10.1164/ajrccm/139.3.806
  18. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol. 2000;105(3):399-408. https://doi.org/10.1067/mai.2000.104575
  19. Lee SY, In KH. Immunopathogenesis of Asthma. Tuberculosis and Respiratory Diseases. 2006;60(4);379-90. https://doi.org/10.4046/trd.2006.60.4.379
  20. Lee SJ, Lee JS, Lee KS. The Effect of Allergen-Specific Immunotherapy on IL-10 and IL-13 mRNA Expression in Peripheral Blood Mononuclear Cells from Patiens with Atopic Asthma. Pediatr Allergy Respir Dis(Korea). 1999;9(1):40-55.
  21. Pathology. The Korean Society of Pathologist. Seoul:Komunsa. 2004:458.
  22. Harrison internal medicine. The Korean Association of Internal medicine. Vol.2. MIP. 2003:150.
  23. Chinese internal medicine. Shanghai Traditional Chinese Medicine series. Vol. 1. Hongkong:Shangwuyinshu.1975:17-23.
  24. Jeongukhanuigwadaehak Pyegyenaegwahakgyosil. Donguiipyeogyeonaegwahak. Seoul: Gukjin. 2004:486.
  25. Chao YF. Chao Shi Zhy bing Yuan Hou Lun. Seoul: Daesungmunhwasa. 1992:106-17.
  26. Zhu S. Puji Fang. Beijing;Inminwisang Pub. 1982:1789.
  27. Lou Y. Yixuegangmu. Beijing;Chinese herbal Pub.1996:598.
  28. Zhang GB. Translated Gyeongakjeonseo. Vol 2. Seoul: Iljungsa.1992:354-64.
  29. Jung SK, Lee HK. A review study of Wheezing asthma. The journal of K.O.M.S. 1986;7(1):60-7.
  30. Zhu ZH. Dangyesimbubbuje. Seoul:Daesungmunhwasa. 1993:328-33.
  31. Wang KT. Zheng zhì zhunsheng. Vol.1. Beijing:Inminwisang Pub. 1991:229-31.
  32. Hwang WS, Lee JS, Choi JY, Jung HJ, Rhee HK, Jung SK. Two cases of Chronic Sinusitis with Asthma Improved by Socheongryong-Tang. The journal of K.O.M.S. 2003;24(1):207-12.
  33. Lee JU, Jeong HJ, Jeong SG, Lee HG. The Effects of Socheongryong-Tang on Lymphocytes in BALF of rat. K.H.M. 2001;17(2):242-53.
  34. Kim JJ, Jeong HJ, Jeong SG, Lee HG. The Effects of Maekmoondong-tang and Jeongcheonhwadamgangki- tang on Immune Cell and Serum OA-specific IgE in BALF in Rat Asthma Model. The Journal of Korean Oriental Medicine. 2002;23(1):7-49.
  35. Kim SS, Jeong HJ, Jeong SG, Lee HG. The Effects of Shinbi-tang and Gamishinbi-tang on Immune Cell and Serum OA-specific IgE in BALF in Rat Asthma Model. The Journal of Korean Oriental Medicine. 2002;23(2):198-210.
  36. Yeom JH, Jung HJ, Jung SG, Lee HG. The Effects of Jungchun-tang and Jungchuntanggagambang on Immune Cell & Serum IgE in BALF in a Rat Asthma Model. The Journal of Korean Oriental Medicine. 2003;24(1):169-80.
  37. Jeong SG, Joo CY, Hwang WS, Lee JS, Jo IH, Jeong HJ. The Journal of Korean Oriental Medicine. The Journal of Korean Oriental Medicine. 2002;23(4):151-60.
  38. Jo IH, Jeong HJ, Lee HG, Jeong SGi ).The Effects of Sabaek-san on Asthma in view of molecular bilogic methods. K.H.M. 2001;17(2):214-29.
  39. Hong CS, Kim KU. Bronchial Asthma- Pathgenesis and Epidemiology. Allergy Asthma Respir Dis. Asthma and Allergic Disease, Seoul: Koonja publishment co. 2002:237-56.
  40. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol. 1986;77(4):527-37. https://doi.org/10.1016/0091-6749(86)90341-6
  41. Rhee YK. Eosinophils in Asthma. Tuberculosis and Respiratory Diseases. 1999;16(1):5-16.
  42. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA. Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils. Science. 2004;305(5691):1773-6. https://doi.org/10.1126/science.1099472
  43. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, Gerard C. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305(5691):1776-9. https://doi.org/10.1126/science.1100283
  44. Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, Hamid Q, Elias JA. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science. 2004;304(5677):1678-82. https://doi.org/10.1126/science.1095336
  45. Jinquan T, Quan S, Jacobi HH, Reimert CM, Millner A, Hansen JB, Thygesen C, Ryder LP, Madsen HO, Malling HJ, Poulsen LK. Cutting edge: expression of the NF of activated T cells in eosinophils: regulation by IL-4 and IL-5. J Immunol. 1999;163(1):21-4.
  46. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989;320(5):271-7. https://doi.org/10.1056/NEJM198902023200502
  47. Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol. 2000;97(1):43-9. https://doi.org/10.1006/clim.2000.4914
  48. Punnonen J, Aversa G, Cocks BG, de Vries JE. Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells. Allergy. 1994;49(8):576-86. https://doi.org/10.1111/j.1398-9995.1994.tb00122.x
  49. Steinke JW, Borish L. Th2 cytokines and sathma. Interleukin-4:its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2001;2(2):66-70. https://doi.org/10.1186/rr40
  50. Kawano T, Matsuse H, Obase Y, Kondo Y, Machida I, Tomari S, Mitsuta K, Fukushima C, Shimoda T, Kohno S. Hypogammaglobul inemia in steroiddependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch Allergy Immunol. 2002l;128(3):240-3. https://doi.org/10.1159/000064258

피인용 문헌

  1. 후박마황탕(厚朴麻黃湯)이 ovalbumin으로 유도된 천식 모델 생쥐에 미치는 영향 vol.39, pp.4, 2014, https://doi.org/10.22246/jikm.2018.39.4.451